- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- hetero-12-12-mer
- Ligands
- 40 x GOL: GLYCEROL(Non-functional Binders)
- 44 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 4 residues within 4Å:- Chain A: N.37, R.38, T.105, H.107
Ligand excluded by PLIPSO4.3: 3 residues within 4Å:- Chain A: P.42, H.48, K.180
Ligand excluded by PLIPSO4.16: 4 residues within 4Å:- Chain B: R.109, L.119, D.120, P.121
Ligand excluded by PLIPSO4.27: 3 residues within 4Å:- Chain C: N.37, T.105, H.107
Ligand excluded by PLIPSO4.34: 4 residues within 4Å:- Chain D: R.109, L.119, P.121
- Ligands: GOL.32
Ligand excluded by PLIPSO4.36: 7 residues within 4Å:- Chain B: L.20, R.33
- Chain D: L.20
- Chain F: L.20
- Ligands: DHB.11, DHB.12, DHB.31
Ligand excluded by PLIPSO4.43: 4 residues within 4Å:- Chain E: N.37, R.38, T.105, H.107
Ligand excluded by PLIPSO4.44: 4 residues within 4Å:- Chain C: Q.163
- Chain E: H.61, L.62, R.64
Ligand excluded by PLIPSO4.45: 3 residues within 4Å:- Chain E: T.98, F.99, D.100
Ligand excluded by PLIPSO4.46: 2 residues within 4Å:- Chain E: R.38, H.107
Ligand excluded by PLIPSO4.52: 3 residues within 4Å:- Chain F: R.109, D.120, P.121
Ligand excluded by PLIPSO4.61: 4 residues within 4Å:- Chain G: N.37, R.38, T.105, H.107
Ligand excluded by PLIPSO4.62: 3 residues within 4Å:- Chain G: P.42, H.48, K.180
Ligand excluded by PLIPSO4.75: 4 residues within 4Å:- Chain H: R.109, L.119, D.120, P.121
Ligand excluded by PLIPSO4.86: 3 residues within 4Å:- Chain I: N.37, T.105, H.107
Ligand excluded by PLIPSO4.93: 4 residues within 4Å:- Chain J: R.109, L.119, P.121
- Ligands: GOL.91
Ligand excluded by PLIPSO4.95: 7 residues within 4Å:- Chain H: L.20, R.33
- Chain J: L.20
- Chain L: L.20
- Ligands: DHB.70, DHB.71, DHB.90
Ligand excluded by PLIPSO4.102: 4 residues within 4Å:- Chain K: N.37, R.38, T.105, H.107
Ligand excluded by PLIPSO4.103: 4 residues within 4Å:- Chain I: Q.163
- Chain K: H.61, L.62, R.64
Ligand excluded by PLIPSO4.104: 3 residues within 4Å:- Chain K: T.98, F.99, D.100
Ligand excluded by PLIPSO4.105: 2 residues within 4Å:- Chain K: R.38, H.107
Ligand excluded by PLIPSO4.111: 3 residues within 4Å:- Chain L: R.109, D.120, P.121
Ligand excluded by PLIPSO4.120: 4 residues within 4Å:- Chain M: N.37, R.38, T.105, H.107
Ligand excluded by PLIPSO4.121: 3 residues within 4Å:- Chain M: P.42, H.48, K.180
Ligand excluded by PLIPSO4.134: 4 residues within 4Å:- Chain N: R.109, L.119, D.120, P.121
Ligand excluded by PLIPSO4.145: 3 residues within 4Å:- Chain O: N.37, T.105, H.107
Ligand excluded by PLIPSO4.152: 4 residues within 4Å:- Chain P: R.109, L.119, P.121
- Ligands: GOL.150
Ligand excluded by PLIPSO4.154: 7 residues within 4Å:- Chain N: L.20, R.33
- Chain P: L.20
- Chain R: L.20
- Ligands: DHB.129, DHB.130, DHB.149
Ligand excluded by PLIPSO4.161: 4 residues within 4Å:- Chain Q: N.37, R.38, T.105, H.107
Ligand excluded by PLIPSO4.162: 4 residues within 4Å:- Chain O: Q.163
- Chain Q: H.61, L.62, R.64
Ligand excluded by PLIPSO4.163: 3 residues within 4Å:- Chain Q: T.98, F.99, D.100
Ligand excluded by PLIPSO4.164: 2 residues within 4Å:- Chain Q: R.38, H.107
Ligand excluded by PLIPSO4.170: 3 residues within 4Å:- Chain R: R.109, D.120, P.121
Ligand excluded by PLIPSO4.179: 4 residues within 4Å:- Chain S: N.37, R.38, T.105, H.107
Ligand excluded by PLIPSO4.180: 3 residues within 4Å:- Chain S: P.42, H.48, K.180
Ligand excluded by PLIPSO4.193: 4 residues within 4Å:- Chain T: R.109, L.119, D.120, P.121
Ligand excluded by PLIPSO4.204: 3 residues within 4Å:- Chain U: N.37, T.105, H.107
Ligand excluded by PLIPSO4.211: 4 residues within 4Å:- Chain V: R.109, L.119, P.121
- Ligands: GOL.209
Ligand excluded by PLIPSO4.213: 7 residues within 4Å:- Chain T: L.20, R.33
- Chain V: L.20
- Chain X: L.20
- Ligands: DHB.188, DHB.189, DHB.208
Ligand excluded by PLIPSO4.220: 4 residues within 4Å:- Chain W: N.37, R.38, T.105, H.107
Ligand excluded by PLIPSO4.221: 4 residues within 4Å:- Chain U: Q.163
- Chain W: H.61, L.62, R.64
Ligand excluded by PLIPSO4.222: 3 residues within 4Å:- Chain W: T.98, F.99, D.100
Ligand excluded by PLIPSO4.223: 2 residues within 4Å:- Chain W: R.38, H.107
Ligand excluded by PLIPSO4.229: 3 residues within 4Å:- Chain X: R.109, D.120, P.121
Ligand excluded by PLIP- 92 x BME: BETA-MERCAPTOETHANOL(Non-functional Binders)
BME.4: 4 residues within 4Å:- Chain A: P.1, I.2, E.3
- Chain P: K.207
Ligand excluded by PLIPBME.5: 2 residues within 4Å:- Chain A: P.164, R.167
Ligand excluded by PLIPBME.7: 8 residues within 4Å:- Chain A: R.38, L.39, A.40, K.41, L.85, N.87, A.88, N.90
Ligand excluded by PLIPBME.8: 3 residues within 4Å:- Chain A: L.52, C.175, R.184
Ligand excluded by PLIPBME.17: 3 residues within 4Å:- Chain B: R.107, P.118, L.119
Ligand excluded by PLIPBME.18: 3 residues within 4Å:- Chain B: H.234, F.235, E.236
Ligand excluded by PLIPBME.20: 6 residues within 4Å:- Chain B: R.150, P.153
- Chain F: S.38, I.39, P.40
- Chain H: P.215
Ligand excluded by PLIPBME.22: 5 residues within 4Å:- Chain B: H.61, C.129, L.130, Y.137, S.138
Ligand excluded by PLIPBME.23: 8 residues within 4Å:- Chain B: R.7, F.8, I.10, Q.41, R.231
- Chain P: N.211, A.213, P.215
Ligand excluded by PLIPBME.24: 6 residues within 4Å:- Chain B: S.38, I.39, P.40
- Chain D: R.150, P.153
- Chain P: M.216
Ligand excluded by PLIPBME.25: 3 residues within 4Å:- Chain B: R.83, Y.136, D.224
Ligand excluded by PLIPBME.28: 2 residues within 4Å:- Chain C: C.175, R.184
Ligand excluded by PLIPBME.37: 3 residues within 4Å:- Chain D: H.234, F.235, E.236
Ligand excluded by PLIPBME.38: 3 residues within 4Å:- Chain D: N.14, K.18, A.196
Ligand excluded by PLIPBME.40: 3 residues within 4Å:- Chain D: H.61, C.129, L.130
Ligand excluded by PLIPBME.42: 6 residues within 4Å:- Chain D: S.38, I.39, P.40
- Chain F: R.150, P.153
- Chain X: P.215
Ligand excluded by PLIPBME.48: 6 residues within 4Å:- Chain E: E.168, T.169, I.171, R.184, F.185, D.186
Ligand excluded by PLIPBME.51: 4 residues within 4Å:- Chain F: H.61, C.129, L.130, S.138
Ligand excluded by PLIPBME.53: 2 residues within 4Å:- Chain F: D.132, S.133
Ligand excluded by PLIPBME.54: 4 residues within 4Å:- Chain F: T.233, H.234, F.235, E.236
Ligand excluded by PLIPBME.57: 6 residues within 4Å:- Chain F: I.205, K.207, R.222, F.223, D.224
- Chain U: I.2
Ligand excluded by PLIPBME.58: 8 residues within 4Å:- Chain F: M.210, N.211, A.213, P.215
- Chain V: F.8, I.10, Q.41, R.231
Ligand excluded by PLIPBME.59: 2 residues within 4Å:- Chain F: K.193, A.196
Ligand excluded by PLIPBME.63: 4 residues within 4Å:- Chain G: P.1, I.2, E.3
- Chain V: K.207
Ligand excluded by PLIPBME.64: 2 residues within 4Å:- Chain G: P.164, R.167
Ligand excluded by PLIPBME.66: 8 residues within 4Å:- Chain G: R.38, L.39, A.40, K.41, L.85, N.87, A.88, N.90
Ligand excluded by PLIPBME.67: 3 residues within 4Å:- Chain G: L.52, C.175, R.184
Ligand excluded by PLIPBME.76: 3 residues within 4Å:- Chain H: R.107, P.118, L.119
Ligand excluded by PLIPBME.77: 3 residues within 4Å:- Chain H: H.234, F.235, E.236
Ligand excluded by PLIPBME.79: 6 residues within 4Å:- Chain B: P.215
- Chain H: R.150, P.153
- Chain L: S.38, I.39, P.40
Ligand excluded by PLIPBME.81: 5 residues within 4Å:- Chain H: H.61, C.129, L.130, Y.137, S.138
Ligand excluded by PLIPBME.82: 8 residues within 4Å:- Chain H: R.7, F.8, I.10, Q.41, R.231
- Chain V: N.211, A.213, P.215
Ligand excluded by PLIPBME.83: 6 residues within 4Å:- Chain H: S.38, I.39, P.40
- Chain J: R.150, P.153
- Chain V: M.216
Ligand excluded by PLIPBME.84: 3 residues within 4Å:- Chain H: R.83, Y.136, D.224
Ligand excluded by PLIPBME.87: 2 residues within 4Å:- Chain I: C.175, R.184
Ligand excluded by PLIPBME.96: 3 residues within 4Å:- Chain J: H.234, F.235, E.236
Ligand excluded by PLIPBME.97: 3 residues within 4Å:- Chain J: N.14, K.18, A.196
Ligand excluded by PLIPBME.99: 3 residues within 4Å:- Chain J: H.61, C.129, L.130
Ligand excluded by PLIPBME.101: 6 residues within 4Å:- Chain J: S.38, I.39, P.40
- Chain L: R.150, P.153
- Chain R: P.215
Ligand excluded by PLIPBME.107: 6 residues within 4Å:- Chain K: E.168, T.169, I.171, R.184, F.185, D.186
Ligand excluded by PLIPBME.110: 4 residues within 4Å:- Chain L: H.61, C.129, L.130, S.138
Ligand excluded by PLIPBME.112: 2 residues within 4Å:- Chain L: D.132, S.133
Ligand excluded by PLIPBME.113: 4 residues within 4Å:- Chain L: T.233, H.234, F.235, E.236
Ligand excluded by PLIPBME.116: 6 residues within 4Å:- Chain L: I.205, K.207, R.222, F.223, D.224
- Chain O: I.2
Ligand excluded by PLIPBME.117: 8 residues within 4Å:- Chain L: M.210, N.211, A.213, P.215
- Chain P: F.8, I.10, Q.41, R.231
Ligand excluded by PLIPBME.118: 2 residues within 4Å:- Chain L: K.193, A.196
Ligand excluded by PLIPBME.122: 4 residues within 4Å:- Chain D: K.207
- Chain M: P.1, I.2, E.3
Ligand excluded by PLIPBME.123: 2 residues within 4Å:- Chain M: P.164, R.167
Ligand excluded by PLIPBME.125: 8 residues within 4Å:- Chain M: R.38, L.39, A.40, K.41, L.85, N.87, A.88, N.90
Ligand excluded by PLIPBME.126: 3 residues within 4Å:- Chain M: L.52, C.175, R.184
Ligand excluded by PLIPBME.135: 3 residues within 4Å:- Chain N: R.107, P.118, L.119
Ligand excluded by PLIPBME.136: 3 residues within 4Å:- Chain N: H.234, F.235, E.236
Ligand excluded by PLIPBME.138: 6 residues within 4Å:- Chain N: R.150, P.153
- Chain R: S.38, I.39, P.40
- Chain T: P.215
Ligand excluded by PLIPBME.140: 5 residues within 4Å:- Chain N: H.61, C.129, L.130, Y.137, S.138
Ligand excluded by PLIPBME.141: 8 residues within 4Å:- Chain D: N.211, A.213, P.215
- Chain N: R.7, F.8, I.10, Q.41, R.231
Ligand excluded by PLIPBME.142: 6 residues within 4Å:- Chain D: M.216
- Chain N: S.38, I.39, P.40
- Chain P: R.150, P.153
Ligand excluded by PLIPBME.143: 3 residues within 4Å:- Chain N: R.83, Y.136, D.224
Ligand excluded by PLIPBME.146: 2 residues within 4Å:- Chain O: C.175, R.184
Ligand excluded by PLIPBME.155: 3 residues within 4Å:- Chain P: H.234, F.235, E.236
Ligand excluded by PLIPBME.156: 3 residues within 4Å:- Chain P: N.14, K.18, A.196
Ligand excluded by PLIPBME.158: 3 residues within 4Å:- Chain P: H.61, C.129, L.130
Ligand excluded by PLIPBME.160: 6 residues within 4Å:- Chain L: P.215
- Chain P: S.38, I.39, P.40
- Chain R: R.150, P.153
Ligand excluded by PLIPBME.166: 6 residues within 4Å:- Chain Q: E.168, T.169, I.171, R.184, F.185, D.186
Ligand excluded by PLIPBME.169: 4 residues within 4Å:- Chain R: H.61, C.129, L.130, S.138
Ligand excluded by PLIPBME.171: 2 residues within 4Å:- Chain R: D.132, S.133
Ligand excluded by PLIPBME.172: 4 residues within 4Å:- Chain R: T.233, H.234, F.235, E.236
Ligand excluded by PLIPBME.175: 6 residues within 4Å:- Chain I: I.2
- Chain R: I.205, K.207, R.222, F.223, D.224
Ligand excluded by PLIPBME.176: 8 residues within 4Å:- Chain J: F.8, I.10, Q.41, R.231
- Chain R: M.210, N.211, A.213, P.215
Ligand excluded by PLIPBME.177: 2 residues within 4Å:- Chain R: K.193, A.196
Ligand excluded by PLIPBME.181: 4 residues within 4Å:- Chain J: K.207
- Chain S: P.1, I.2, E.3
Ligand excluded by PLIPBME.182: 2 residues within 4Å:- Chain S: P.164, R.167
Ligand excluded by PLIPBME.184: 8 residues within 4Å:- Chain S: R.38, L.39, A.40, K.41, L.85, N.87, A.88, N.90
Ligand excluded by PLIPBME.185: 3 residues within 4Å:- Chain S: L.52, C.175, R.184
Ligand excluded by PLIPBME.194: 3 residues within 4Å:- Chain T: R.107, P.118, L.119
Ligand excluded by PLIPBME.195: 3 residues within 4Å:- Chain T: H.234, F.235, E.236
Ligand excluded by PLIPBME.197: 6 residues within 4Å:- Chain N: P.215
- Chain T: R.150, P.153
- Chain X: S.38, I.39, P.40
Ligand excluded by PLIPBME.199: 5 residues within 4Å:- Chain T: H.61, C.129, L.130, Y.137, S.138
Ligand excluded by PLIPBME.200: 8 residues within 4Å:- Chain J: N.211, A.213, P.215
- Chain T: R.7, F.8, I.10, Q.41, R.231
Ligand excluded by PLIPBME.201: 6 residues within 4Å:- Chain J: M.216
- Chain T: S.38, I.39, P.40
- Chain V: R.150, P.153
Ligand excluded by PLIPBME.202: 3 residues within 4Å:- Chain T: R.83, Y.136, D.224
Ligand excluded by PLIPBME.205: 2 residues within 4Å:- Chain U: C.175, R.184
Ligand excluded by PLIPBME.214: 3 residues within 4Å:- Chain V: H.234, F.235, E.236
Ligand excluded by PLIPBME.215: 3 residues within 4Å:- Chain V: N.14, K.18, A.196
Ligand excluded by PLIPBME.217: 3 residues within 4Å:- Chain V: H.61, C.129, L.130
Ligand excluded by PLIPBME.219: 6 residues within 4Å:- Chain F: P.215
- Chain V: S.38, I.39, P.40
- Chain X: R.150, P.153
Ligand excluded by PLIPBME.225: 6 residues within 4Å:- Chain W: E.168, T.169, I.171, R.184, F.185, D.186
Ligand excluded by PLIPBME.228: 4 residues within 4Å:- Chain X: H.61, C.129, L.130, S.138
Ligand excluded by PLIPBME.230: 2 residues within 4Å:- Chain X: D.132, S.133
Ligand excluded by PLIPBME.231: 4 residues within 4Å:- Chain X: T.233, H.234, F.235, E.236
Ligand excluded by PLIPBME.234: 6 residues within 4Å:- Chain C: I.2
- Chain X: I.205, K.207, R.222, F.223, D.224
Ligand excluded by PLIPBME.235: 8 residues within 4Å:- Chain D: F.8, I.10, Q.41, R.231
- Chain X: M.210, N.211, A.213, P.215
Ligand excluded by PLIPBME.236: 2 residues within 4Å:- Chain X: K.193, A.196
Ligand excluded by PLIP- 24 x CL: CHLORIDE ION(Non-functional Binders)
CL.6: 1 residues within 4Å:- Chain A: R.167
Ligand excluded by PLIPCL.19: 2 residues within 4Å:- Chain B: D.132, S.133
Ligand excluded by PLIPCL.21: 1 residues within 4Å:- Chain B: A.58
Ligand excluded by PLIPCL.39: 1 residues within 4Å:- Chain D: D.224
Ligand excluded by PLIPCL.47: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.55: 2 residues within 4Å:- Chain F: R.107, L.119
Ligand excluded by PLIPCL.65: 1 residues within 4Å:- Chain G: R.167
Ligand excluded by PLIPCL.78: 2 residues within 4Å:- Chain H: D.132, S.133
Ligand excluded by PLIPCL.80: 1 residues within 4Å:- Chain H: A.58
Ligand excluded by PLIPCL.98: 1 residues within 4Å:- Chain J: D.224
Ligand excluded by PLIPCL.106: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.114: 2 residues within 4Å:- Chain L: R.107, L.119
Ligand excluded by PLIPCL.124: 1 residues within 4Å:- Chain M: R.167
Ligand excluded by PLIPCL.137: 2 residues within 4Å:- Chain N: D.132, S.133
Ligand excluded by PLIPCL.139: 1 residues within 4Å:- Chain N: A.58
Ligand excluded by PLIPCL.157: 1 residues within 4Å:- Chain P: D.224
Ligand excluded by PLIPCL.165: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.173: 2 residues within 4Å:- Chain R: R.107, L.119
Ligand excluded by PLIPCL.183: 1 residues within 4Å:- Chain S: R.167
Ligand excluded by PLIPCL.196: 2 residues within 4Å:- Chain T: D.132, S.133
Ligand excluded by PLIPCL.198: 1 residues within 4Å:- Chain T: A.58
Ligand excluded by PLIPCL.216: 1 residues within 4Å:- Chain V: D.224
Ligand excluded by PLIPCL.224: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.232: 2 residues within 4Å:- Chain X: R.107, L.119
Ligand excluded by PLIP- 12 x FE: FE (III) ION(Non-covalent)
FE.9: 4 residues within 4Å:- Chain B: Y.108, H.160, H.162
- Ligands: DHB.10
3 PLIP interactions:3 interactions with chain B- Metal complexes: B:Y.108, B:H.160, B:H.162
FE.29: 5 residues within 4Å:- Chain D: Y.108, R.157, H.160, H.162
- Ligands: DHB.30
3 PLIP interactions:3 interactions with chain D- Metal complexes: D:Y.108, D:H.160, D:H.162
FE.49: 4 residues within 4Å:- Chain F: Y.108, H.160, H.162
- Ligands: DHB.50
3 PLIP interactions:3 interactions with chain F- Metal complexes: F:Y.108, F:H.160, F:H.162
FE.68: 4 residues within 4Å:- Chain H: Y.108, H.160, H.162
- Ligands: DHB.69
3 PLIP interactions:3 interactions with chain H- Metal complexes: H:Y.108, H:H.160, H:H.162
FE.88: 5 residues within 4Å:- Chain J: Y.108, R.157, H.160, H.162
- Ligands: DHB.89
3 PLIP interactions:3 interactions with chain J- Metal complexes: J:Y.108, J:H.160, J:H.162
FE.108: 4 residues within 4Å:- Chain L: Y.108, H.160, H.162
- Ligands: DHB.109
3 PLIP interactions:3 interactions with chain L- Metal complexes: L:Y.108, L:H.160, L:H.162
FE.127: 4 residues within 4Å:- Chain N: Y.108, H.160, H.162
- Ligands: DHB.128
3 PLIP interactions:3 interactions with chain N- Metal complexes: N:Y.108, N:H.160, N:H.162
FE.147: 5 residues within 4Å:- Chain P: Y.108, R.157, H.160, H.162
- Ligands: DHB.148
3 PLIP interactions:3 interactions with chain P- Metal complexes: P:Y.108, P:H.160, P:H.162
FE.167: 4 residues within 4Å:- Chain R: Y.108, H.160, H.162
- Ligands: DHB.168
3 PLIP interactions:3 interactions with chain R- Metal complexes: R:Y.108, R:H.160, R:H.162
FE.186: 4 residues within 4Å:- Chain T: Y.108, H.160, H.162
- Ligands: DHB.187
3 PLIP interactions:3 interactions with chain T- Metal complexes: T:Y.108, T:H.160, T:H.162
FE.206: 5 residues within 4Å:- Chain V: Y.108, R.157, H.160, H.162
- Ligands: DHB.207
3 PLIP interactions:3 interactions with chain V- Metal complexes: V:Y.108, V:H.160, V:H.162
FE.226: 4 residues within 4Å:- Chain X: Y.108, H.160, H.162
- Ligands: DHB.227
3 PLIP interactions:3 interactions with chain X- Metal complexes: X:Y.108, X:H.160, X:H.162
- 24 x DHB: 3,4-DIHYDROXYBENZOIC ACID(Non-covalent)
DHB.10: 12 residues within 4Å:- Chain A: P.15, Y.16
- Chain B: Y.24, Y.108, H.147, W.149, R.157, H.160, H.162, Q.177, I.191
- Ligands: FE.9
Ligand excluded by PLIPDHB.11: 7 residues within 4Å:- Chain B: L.20, P.22, I.28, R.33
- Chain F: L.20, R.33
- Ligands: SO4.36
Ligand excluded by PLIPDHB.12: 7 residues within 4Å:- Chain B: K.18, R.33
- Chain D: L.20, P.22, I.28, R.33
- Ligands: SO4.36
Ligand excluded by PLIPDHB.30: 13 residues within 4Å:- Chain C: G.14, P.15, R.133
- Chain D: Y.24, Y.108, H.147, W.149, R.157, H.160, H.162, Q.177, I.191
- Ligands: FE.29
Ligand excluded by PLIPDHB.31: 6 residues within 4Å:- Chain D: R.33
- Chain F: L.20, P.22, I.28, R.33
- Ligands: SO4.36
Ligand excluded by PLIPDHB.50: 14 residues within 4Å:- Chain E: G.14, P.15, Y.16, R.133
- Chain F: Y.24, Y.108, H.147, W.149, R.157, H.160, H.162, Q.177, I.191
- Ligands: FE.49
Ligand excluded by PLIPDHB.69: 12 residues within 4Å:- Chain G: P.15, Y.16
- Chain H: Y.24, Y.108, H.147, W.149, R.157, H.160, H.162, Q.177, I.191
- Ligands: FE.68
Ligand excluded by PLIPDHB.70: 7 residues within 4Å:- Chain H: L.20, P.22, I.28, R.33
- Chain L: L.20, R.33
- Ligands: SO4.95
Ligand excluded by PLIPDHB.71: 7 residues within 4Å:- Chain H: K.18, R.33
- Chain J: L.20, P.22, I.28, R.33
- Ligands: SO4.95
Ligand excluded by PLIPDHB.89: 13 residues within 4Å:- Chain I: G.14, P.15, R.133
- Chain J: Y.24, Y.108, H.147, W.149, R.157, H.160, H.162, Q.177, I.191
- Ligands: FE.88
Ligand excluded by PLIPDHB.90: 6 residues within 4Å:- Chain J: R.33
- Chain L: L.20, P.22, I.28, R.33
- Ligands: SO4.95
Ligand excluded by PLIPDHB.109: 14 residues within 4Å:- Chain K: G.14, P.15, Y.16, R.133
- Chain L: Y.24, Y.108, H.147, W.149, R.157, H.160, H.162, Q.177, I.191
- Ligands: FE.108
Ligand excluded by PLIPDHB.128: 12 residues within 4Å:- Chain M: P.15, Y.16
- Chain N: Y.24, Y.108, H.147, W.149, R.157, H.160, H.162, Q.177, I.191
- Ligands: FE.127
Ligand excluded by PLIPDHB.129: 7 residues within 4Å:- Chain N: L.20, P.22, I.28, R.33
- Chain R: L.20, R.33
- Ligands: SO4.154
Ligand excluded by PLIPDHB.130: 7 residues within 4Å:- Chain N: K.18, R.33
- Chain P: L.20, P.22, I.28, R.33
- Ligands: SO4.154
Ligand excluded by PLIPDHB.148: 13 residues within 4Å:- Chain O: G.14, P.15, R.133
- Chain P: Y.24, Y.108, H.147, W.149, R.157, H.160, H.162, Q.177, I.191
- Ligands: FE.147
Ligand excluded by PLIPDHB.149: 6 residues within 4Å:- Chain P: R.33
- Chain R: L.20, P.22, I.28, R.33
- Ligands: SO4.154
Ligand excluded by PLIPDHB.168: 14 residues within 4Å:- Chain Q: G.14, P.15, Y.16, R.133
- Chain R: Y.24, Y.108, H.147, W.149, R.157, H.160, H.162, Q.177, I.191
- Ligands: FE.167
Ligand excluded by PLIPDHB.187: 12 residues within 4Å:- Chain S: P.15, Y.16
- Chain T: Y.24, Y.108, H.147, W.149, R.157, H.160, H.162, Q.177, I.191
- Ligands: FE.186
Ligand excluded by PLIPDHB.188: 7 residues within 4Å:- Chain T: L.20, P.22, I.28, R.33
- Chain X: L.20, R.33
- Ligands: SO4.213
Ligand excluded by PLIPDHB.189: 7 residues within 4Å:- Chain T: K.18, R.33
- Chain V: L.20, P.22, I.28, R.33
- Ligands: SO4.213
Ligand excluded by PLIPDHB.207: 13 residues within 4Å:- Chain U: G.14, P.15, R.133
- Chain V: Y.24, Y.108, H.147, W.149, R.157, H.160, H.162, Q.177, I.191
- Ligands: FE.206
Ligand excluded by PLIPDHB.208: 6 residues within 4Å:- Chain V: R.33
- Chain X: L.20, P.22, I.28, R.33
- Ligands: SO4.213
Ligand excluded by PLIPDHB.227: 14 residues within 4Å:- Chain W: G.14, P.15, Y.16, R.133
- Chain X: Y.24, Y.108, H.147, W.149, R.157, H.160, H.162, Q.177, I.191
- Ligands: FE.226
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Purpero, V.M. et al., Tyrosine 447 of Protocatechuate 34,-Dioxygenase Controls Efficient Progress Through Catalysis. To be Published
- Release Date
- 2011-02-16
- Peptides
- Protocatechuate 3,4-dioxygenase alpha chain: ACEGIKMOQSUW
Protocatechuate 3,4-dioxygenase beta chain: BDFHJLNPRTVX - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
BE
CG
AI
BK
CM
AO
BQ
CS
AU
BW
CB
MD
NF
OH
MJ
NL
ON
MP
NR
OT
MV
NX
O
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- hetero-12-12-mer
- Ligands
- 40 x GOL: GLYCEROL(Non-functional Binders)
- 44 x SO4: SULFATE ION(Non-functional Binders)
- 92 x BME: BETA-MERCAPTOETHANOL(Non-functional Binders)
- 24 x CL: CHLORIDE ION(Non-functional Binders)
- 12 x FE: FE (III) ION(Non-covalent)
- 24 x DHB: 3,4-DIHYDROXYBENZOIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Purpero, V.M. et al., Tyrosine 447 of Protocatechuate 34,-Dioxygenase Controls Efficient Progress Through Catalysis. To be Published
- Release Date
- 2011-02-16
- Peptides
- Protocatechuate 3,4-dioxygenase alpha chain: ACEGIKMOQSUW
Protocatechuate 3,4-dioxygenase beta chain: BDFHJLNPRTVX - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
BE
CG
AI
BK
CM
AO
BQ
CS
AU
BW
CB
MD
NF
OH
MJ
NL
ON
MP
NR
OT
MV
NX
O